2015 ESC Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-segment Elevation.

[1]  N. Roubinian,et al.  Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. , 2016, The Cochrane database of systematic reviews.

[2]  David R Thompson,et al.  Exercise-based cardiac rehabilitation for coronary heart disease. , 2016, The Cochrane database of systematic reviews.

[3]  Y. Dundar,et al.  Drug-eluting stents versus bare metal stents for angina or acute coronary syndromes. , 2015, The Cochrane database of systematic reviews.

[4]  Christian Schindler,et al.  One-hour rule-in and rule-out of acute myocardial infarction using high-sensitivity cardiac troponin I. , 2015, The American journal of medicine.

[5]  Improve-It Investigators.  Ezetimibe added to statin therapy after acute coronary syndromes , 2015 .

[6]  Walter Desmet,et al.  ISAR-SAFE: a randomized, double-blind, placebo-controlled trial of 6 vs. 12 months of clopidogrel therapy after drug-eluting stenting. , 2015, European heart journal.

[7]  Marc P. Bonaca,et al.  Long-term use of ticagrelor in patients with prior myocardial infarction. , 2015, The New England journal of medicine.

[8]  C. Patrono,et al.  Cyclooxygenase inhibitors: From pharmacology to clinical read-outs. , 2015, Biochimica et biophysica acta.

[9]  J. Wetterslev,et al.  Restrictive versus liberal transfusion strategy for red blood cell transfusion: systematic review of randomised trials with meta-analysis and trial sequential analysis , 2015, BMJ : British Medical Journal.

[10]  G. Angelini,et al.  Liberal or restrictive transfusion after cardiac surgery. , 2015, The New England journal of medicine.

[11]  J. Wójcik,et al.  6- versus 24-month dual antiplatelet therapy after implantation of drug-eluting stents in patients nonresistant to aspirin: the randomized, multicenter ITALIC trial. , 2015, Journal of the American College of Cardiology.

[12]  J. Carrero,et al.  Association between the use of fondaparinux vs low-molecular-weight heparin and clinical outcomes in patients with non-ST-segment elevation myocardial infarction. , 2015, JAMA.

[13]  J. Zamorano,et al.  The use of echocardiography in acute cardiovascular care: recommendations of the European Association of Cardiovascular Imaging and the Acute Cardiovascular Care Association. , 2015, European heart journal cardiovascular Imaging.

[14]  P. Doherty,et al.  Challenges in secondary prevention of cardiovascular diseases: a review of the current practice. , 2015, International journal of cardiology.

[15]  O. Senn,et al.  Diagnostic performance of reproducible chest wall tenderness to rule out acute coronary syndrome in acute chest pain: a prospective diagnostic study , 2015, BMJ Open.

[16]  C. Hengstenberg,et al.  Comparison of vascular closure devices vs manual compression after femoral artery puncture: the ISAR-CLOSURE randomized clinical trial. , 2014, JAMA.

[17]  E. Omerovic,et al.  Outcomes 1 year after thrombus aspiration for myocardial infarction. , 2014, The New England journal of medicine.

[18]  Akshay S. Desai,et al.  Angiotensin-neprilysin inhibition versus enalapril in heart failure. , 2014, The New England journal of medicine.

[19]  H. White,et al.  Long-term outcomes associated with hospital acquired thrombocytopenia among patients with non-ST-segment elevation acute coronary syndrome. , 2014, American heart journal.

[20]  Brian J. McCourt,et al.  A registry-based randomized trial comparing radial and femoral approaches in women undergoing percutaneous coronary intervention: the SAFE-PCI for Women (Study of Access Site for Enhancement of PCI for Women) trial. , 2014, JACC. Cardiovascular interventions.

[21]  J. Beyer-Westendorf,et al.  Peri-interventional management of novel oral anticoagulants in daily care: results from the prospective Dresden NOAC registry. , 2014, European heart journal.

[22]  R. Ljung,et al.  Undetectable high-sensitivity cardiac troponin T level in the emergency department and risk of myocardial infarction. , 2014, Journal of the American College of Cardiology.

[23]  A. Go,et al.  Comparative effectiveness of clopidogrel in medically managed patients with unstable angina and non-ST-segment elevation myocardial infarction. , 2014, Journal of the American College of Cardiology.

[24]  G. Lippi,et al.  The concentration of troponin I is increased in patients with acute-onset atrial fibrillation. , 2014, International journal of cardiology.

[25]  S. de Servi,et al.  Clinical outcomes for prasugrel versus clopidogrel in patients with unstable angina or non-ST-elevation myocardial infarction: an analysis from the TRITON-TIMI 38 trial , 2014, European heart journal. Acute cardiovascular care.

[26]  Robert H Christenson,et al.  Age- and sex-dependent upper reference limits for the high-sensitivity cardiac troponin T assay. , 2014, Journal of the American College of Cardiology.

[27]  Daniel E Forman,et al.  Frailty assessment in the cardiovascular care of older adults. , 2014, Journal of the American College of Cardiology.

[28]  R. Califf,et al.  Outcomes among non-ST-segment elevation acute coronary syndromes patients with no angiographically obstructive coronary artery disease: observations from 37,101 patients , 2014, European heart journal. Acute cardiovascular care.

[29]  C. Hesse,et al.  Effects of ex vivo platelet supplementation on platelet aggregability in blood samples from patients treated with acetylsalicylic acid, clopidogrel, or ticagrelor. , 2014, British journal of anaesthesia.

[30]  E. Peterson,et al.  Patterns and outcomes of red blood cell transfusion in patients undergoing percutaneous coronary intervention. , 2014, JAMA.

[31]  C. Patrono,et al.  Nonsteroidal Anti-Inflammatory Drugs and the Heart , 2014, Circulation.

[32]  D. Chew,et al.  An examination of clinical intuition in risk assessment among acute coronary syndromes patients: observations from a prospective multi-center international observational registry. , 2014, International journal of cardiology.

[33]  S. Windecker,et al.  Invasive coronary treatment strategies for out-of-hospital cardiac arrest: a consensus statement from the European association for percutaneous cardiovascular interventions (EAPCI)/stent for life (SFL) groups. , 2014, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[34]  P. Andersen,et al.  Trends in time to invasive examination and treatment from 2001 to 2009 in patients admitted first time with non-ST elevation myocardial infarction or unstable angina in Denmark , 2014, BMJ Open.

[35]  A. Kastrati,et al.  Collagen plug vascular closure devices and reduced risk of bleeding with bivalirudin versus heparin plus abciximab in patients undergoing percutaneous coronary intervention for non st-segment elevation myocardial infarction. , 2013, Journal of interventional cardiology.

[36]  V. Fuster,et al.  Comparison of coronary artery bypass surgery and percutaneous coronary intervention in patients with diabetes: a meta-analysis of randomised controlled trials. , 2013, The lancet. Diabetes & endocrinology.

[37]  H. Ashrafian,et al.  The effect of off-pump coronary artery bypass on mortality after acute coronary syndrome: a meta-analysis. , 2013, International journal of cardiology.

[38]  G. Schuler,et al.  Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial , 2013, The Lancet.

[39]  D. Atar,et al.  High-Sensitivity Troponin I for Risk Assessment in Patients With Atrial Fibrillation: Insights From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial , 2013, Circulation.

[40]  Mario Fusaro,et al.  Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta-analysis , 2013, BMJ.

[41]  C. Vilaplana,et al.  Rapid rule out of acute myocardial infarction using undetectable levels of high-sensitivity cardiac troponin. , 2013, International journal of cardiology.

[42]  V. Fuster,et al.  Early intravenous beta-blockers in patients with acute coronary syndrome--a meta-analysis of randomized trials. , 2013, International journal of cardiology.

[43]  Hugo A. Katus,et al.  A signature of circulating microRNAs differentiates takotsubo cardiomyopathy from acute myocardial infarction , 2013, European heart journal.

[44]  J. Hodges,et al.  Long-term survival in patients with refractory angina. , 2013, European heart journal.

[45]  H. Schunkert,et al.  Bleeding after percutaneous coronary intervention in women and men matched for age, body mass index, and type of antithrombotic therapy. , 2013, American heart journal.

[46]  X. Y. Zhang,et al.  Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials , 2013, BDJ.

[47]  V. Roger.  Epidemiology of Heart Failure , 2013, Circulation research.

[48]  J. Ambrose,et al.  Frequency of Takotsubo cardiomyopathy in postmenopausal women presenting with an acute coronary syndrome. , 2013, The American journal of cardiology.

[49]  K. Rentsch,et al.  Direct comparison of high-sensitivity-cardiac troponin I vs. T for the early diagnosis of acute myocardial infarction. , 2013, European heart journal.

[50]  B. Uretsky,et al.  Effectiveness of Percutaneous Coronary Intervention With Drug‐Eluting Stents Compared With Bypass Surgery in Diabetics With Multivessel Coronary Disease: Comprehensive Systematic Review and Meta‐analysis of Randomized Clinical Data , 2013, Journal of the American Heart Association.

[51]  S. Maes,et al.  Lifestyle modification programmes for patients with coronary heart disease: a systematic review and meta-analysis of randomized controlled trials , 2013, European journal of preventive cardiology.

[52]  J. Kirklin.  Long-term mechanical circulatory support: could it really have a public health impact? , 2013, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[53]  A. Kastrati,et al.  Prognostic Value of Access and Non–Access Sites Bleeding After Percutaneous Coronary Intervention , 2013, Circulation. Cardiovascular interventions.

[54]  M. Mack,et al.  Quantification of Incomplete Revascularization and its Association With Five-Year Mortality in the Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery (SYNTAX) Trial Validation of the Residual SYNTAX Score , 2013, Circulation.

[55]  J. George,et al.  Approach to the diagnosis and management of drug-induced immune thrombocytopenia. , 2013, Transfusion medicine reviews.

[56]  C. Vilaplana,et al.  Comparison of the performances of cardiac troponins, including sensitive assays, and copeptin in the diagnostic of acute myocardial infarction and long-term prognosis between women and men. , 2013, American heart journal.

[57]  R. Giugliano,et al.  Prevalence and clinical outcomes of undiagnosed diabetes mellitus and prediabetes among patients with high-risk non-ST-segment elevation acute coronary syndrome. , 2013, American heart journal.

[58]  S. Takanashi,et al.  Early and long-term outcomes of coronary artery bypass grafting in patients with acute coronary syndrome versus stable angina pectoris. , 2013, The Journal of thoracic and cardiovascular surgery.

[59]  S. Sasaki,et al.  Presentations of acute coronary syndrome related to coronary lesion morphologies as assessed by intravascular ultrasound and optical coherence tomography. , 2013, International journal of cardiology.

[60]  Nobuhiro Tanaka,et al.  Functional assessment of coronary stenoses: can we live without it? , 2013, European heart journal.

[61]  M. Mack,et al.  Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial. , 2013, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[62]  T. Lehr,et al.  Pharmacometric Characterization of Dabigatran Hemodialysis , 2013, Clinical Pharmacokinetics.

[63]  Ri-tai Huang,et al.  Meta-analysis of clinical studies comparing coronary artery bypass grafting with percutaneous coronary intervention in patients with end-stage renal disease. , 2013, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[64]  Antonio Colombo,et al.  Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial , 2013, The Lancet.

[65]  J. Kelton,et al.  Nonheparin anticoagulants for heparin-induced thrombocytopenia. , 2013, The New England journal of medicine.

[66]  G. Stone,et al.  Optimal Timing of Coronary Invasive Strategy in Non–ST-Segment Elevation Acute Coronary Syndromes , 2013, Annals of Internal Medicine.

[67]  J. Wetterslev,et al.  Association of blood transfusion with increased mortality in myocardial infarction: a meta-analysis and diversity-adjusted study sequential analysis. , 2013, JAMA internal medicine.

[68]  Akshay S. Desai,et al.  Strategies for multivessel revascularization in patients with diabetes. , 2012, The New England journal of medicine.

[69]  W. Winkelmayer,et al.  Multivessel coronary artery bypass grafting versus percutaneous coronary intervention in ESRD. , 2012, Journal of the American Society of Nephrology : JASN.

[70]  S. Kurz,et al.  Introduction of high-sensitivity troponin assays: impact on myocardial infarction incidence and prognosis. , 2012, The American journal of medicine.

[71]  Gerhard Hindricks,et al.  2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation--developed with the special contribution of the European Heart Rhythm Association. , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[72]  Howard K. Song,et al.  2012 update to the Society of Thoracic Surgeons guideline on use of antiplatelet drugs in patients having cardiac and noncardiac operations. , 2012, The Annals of thoracic surgery.

[73]  P. Serruys,et al.  Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial , 2012, The Lancet.

[74]  G. Schuler,et al.  Intraaortic balloon support for myocardial infarction with cardiogenic shock. , 2012, The New England journal of medicine.

[75]  Deepak L. Bhatt,et al.  Prasugrel versus clopidogrel for acute coronary syndromes without revascularization. , 2012, The New England journal of medicine.

[76]  Marissa Miller,et al.  Long-term mechanical circulatory support (destination therapy): on track to compete with heart transplantation? , 2012, The Journal of thoracic and cardiovascular surgery.

[77]  P. Libby.  Inflammation in Atherosclerosis , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[78]  J. Alpert,et al.  How to use high-sensitivity cardiac troponins in acute cardiac care , 2012 .

[79]  S. de Servi,et al.  Early aggressive versus initially conservative treatment in elderly patients with non-ST-segment elevation acute coronary syndrome: a randomized controlled trial. , 2012, JACC. Cardiovascular interventions.

[80]  L. Räber,et al.  Effect of biolimus-eluting stents with biodegradable polymer vs bare-metal stents on cardiovascular events among patients with acute myocardial infarction: the COMFORTABLE AMI randomized trial. , 2012, JAMA.

[81]  G. Schuler,et al.  Optimal timing of invasive angiography in stable non-ST-elevation myocardial infarction: the Leipzig Immediate versus early and late PercutaneouS coronary Intervention triAl in NSTEMI (LIPSIA-NSTEMI Trial). , 2012, European heart journal.

[82]  M. Sabatine,et al.  An invasive or conservative strategy in patients with diabetes mellitus and non-ST-segment elevation acute coronary syndromes: a collaborative meta-analysis of randomized trials. , 2012, Journal of the American College of Cardiology.

[83]  J. Bae,et al.  Rehospitalization following percutaneous coronary intervention for commercially insured patients with acute coronary syndrome: a retrospective analysis , 2012, BMC Research Notes.

[84]  M. Niemelä,et al.  Comparison of additional versus no additional heparin during therapeutic oral anticoagulation in patients undergoing percutaneous coronary intervention. , 2012, The American journal of cardiology.

[85]  W. Wojakowski,et al.  Effects of preoperative aspirin in coronary artery bypass grafting: a double-blind, placebo-controlled, randomized trial. , 2012, The Journal of thoracic and cardiovascular surgery.

[86]  Shah Ebrahim,et al.  European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012) , 2012, International Journal of Behavioral Medicine.

[87]  P. Serruys,et al.  Quantification and impact of untreated coronary artery disease after percutaneous coronary intervention: the residual SYNTAX (Synergy Between PCI with Taxus and Cardiac Surgery) score. , 2012, Journal of the American College of Cardiology.

[88]  D. Angiolillo,et al.  Antithrombotic Therapy in Patients With Chronic Kidney Disease , 2012, Circulation.

[89]  R. Roussel,et al.  Consensus statement on the care of the hyperglycaemic/diabetic patient during and in the immediate follow-up of acute coronary syndrome. , 2012, Diabetes & Metabolism.

[90]  P. Rehak,et al.  Platelet Function Measurement–Based Strategy to Reduce Bleeding and Waiting Time in Clopidogrel-Treated Patients Undergoing Coronary Artery Bypass Graft Surgery: The Timing Based on Platelet Function Strategy to Reduce Clopidogrel-Associated Bleeding Related to CABG (TARGET-CABG) Study , 2012, Circulation. Cardiovascular interventions.

[91]  G. Guyatt,et al.  Association between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery. , 2012, JAMA.

[92]  M. Hadamitzky,et al.  Validation of the Bleeding Academic Research Consortium Definition of Bleeding in Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention , 2012, Circulation.

[93]  R. West,et al.  Resolving inequalities in care? Reduced mortality in the elderly after acute coronary syndromes. The Myocardial Ischaemia National Audit Project 2003-2010. , 2012, European heart journal.

[94]  F. Biancari,et al.  Benefits and risks of using clopidogrel before coronary artery bypass surgery: systematic review and meta-analysis of randomized trials and observational studies. , 2012, The Journal of thoracic and cardiovascular surgery.

[95]  Viola Vaccarino,et al.  Association of age and sex with myocardial infarction symptom presentation and in-hospital mortality. , 2012, JAMA.

[96]  D. Chew,et al.  The impact of increased age on outcome from a strategy of early invasive management and revascularisation in patients with acute coronary syndromes: retrospective analysis study from the ACACIA registry , 2012, BMJ Open.

[97]  Robert L Kormos,et al.  The Fourth INTERMACS Annual Report: 4,000 implants and counting. , 2012, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[98]  Paul Burton,et al.  Rivaroxaban in patients with a recent acute coronary syndrome. , 2012, The New England journal of medicine.

[99]  S. Blankenberg,et al.  Serial changes in highly sensitive troponin I assay and early diagnosis of myocardial infarction. , 2011, JAMA.

[100]  T. Athanasiou,et al.  Safety of clopidogrel being continued until the time of coronary artery bypass grafting in patients with acute coronary syndrome: a meta-analysis of 34 studies. , 2011, European heart journal.

[101]  L. Wallentin,et al.  Similar outcome with an invasive strategy in men and women with non-ST-elevation acute coronary syndromes: from the Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART). , 2011, European heart journal.

[102]  P. Mody,et al.  Frailty Is Independently Associated With Short-Term Outcomes for Elderly Patients With Non – ST-Segment Elevation – Myocardial Infarction , 2012 .

[103]  Jörg Hausleiter,et al.  Abciximab and heparin versus bivalirudin for non-ST-elevation myocardial infarction. , 2011, The New England journal of medicine.

[104]  Li-jun Guo,et al.  The relationship between kidney function and angiographically-derived SYNTAX score. , 2011, The Canadian journal of cardiology.

[105]  M. Roffi,et al.  Current concepts on coronary revascularization in diabetic patients. , 2011, European heart journal.

[106]  A. Moss,et al.  Effect of Elapsed Time From Coronary Revascularization to Implantation of a Cardioverter Defibrillator on Long‐Term Survival in the MADIT‐II Trial , 2011, Journal of cardiovascular electrophysiology.

[107]  K. Anstrom,et al.  Safety and efficacy of drug-eluting stents in older patients with chronic kidney disease: a report from the linked CathPCI Registry-CMS claims database. , 2011, Journal of the American College of Cardiology.

[108]  Sunil V. Rao,et al.  Conservative versus liberal red cell transfusion in acute myocardial infarction (the CRIT Randomized Pilot Study). , 2011, The American journal of cardiology.

[109]  D. Kansagara,et al.  Treatment of Anemia in Patients With Heart Disease , 2013, Annals of Internal Medicine.

[110]  M. Leoncini,et al.  Effects of Hydration in Contrast-Induced Acute Kidney Injury After Primary Angioplasty: A Randomized, Controlled Trial , 2011, Circulation. Cardiovascular interventions.

[111]  T. Akasaka,et al.  Conformational change in coronary artery structure assessed by optical coherence tomography in patients with vasospastic angina. , 2011, Journal of the American College of Cardiology.

[112]  D. Berman,et al.  The CT-STAT (Coronary Computed Tomographic Angiography for Systematic Triage of Acute Chest Pain Patients to Treatment) trial. , 2011, Journal of the American College of Cardiology.

[113]  Betti Giusti,et al.  High residual platelet reactivity after clopidogrel loading and long-term cardiovascular events among patients with acute coronary syndromes undergoing PCI. , 2011, JAMA.

[114]  K. Nikus,et al.  Factors associated with failure to identify the culprit artery by the electrocardiogram in inferior ST-elevation myocardial infarction. , 2011, Journal of electrocardiology.

[115]  Á. Avezum,et al.  Risk stratification in the setting of non-ST elevation acute coronary syndromes 1999-2007. , 2011, The American journal of cardiology.

[116]  C. Hamm,et al.  Improved diagnostic and prognostic performance of a new high-sensitive troponin T assay in patients with acute coronary syndrome. , 2011, American heart journal.

[117]  C. Cannon,et al.  Ticagrelor versus clopidogrel in patients with acute coronary syndromes intended for non-invasive management: substudy from prospective randomised PLATelet inhibition and patient Outcomes (PLATO) trial , 2011, BMJ : British Medical Journal.

[118]  Marco Valgimigli,et al.  Standardized Bleeding Definitions for Cardiovascular Clinical Trials: A Consensus Report From the Bleeding Academic Research Consortium , 2011, Circulation.

[119]  G. Stone,et al.  Prognostic value of the SYNTAX score in patients with acute coronary syndromes undergoing percutaneous coronary intervention: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage StrategY) trial. , 2011, Journal of the American College of Cardiology.

[120]  Samin K. Sharma,et al.  How Serious a Problem is Bleeding in Patients with Acute Coronary Syndromes? , 2011, Current cardiology reports.

[121]  Eugene H Blackstone,et al.  Morbidity of bleeding after cardiac surgery: is it blood transfusion, reoperation for bleeding, or both? , 2011, The Annals of thoracic surgery.

[122]  Li-sheng Liu,et al.  Is a systolic blood pressure target <140 mmHg indicated in all hypertensives? Subgroup analyses of findings from the randomized FEVER trial. , 2011, European heart journal.

[123]  Sunil V. Rao,et al.  Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial , 2011, The Lancet.

[124]  Denis Xavier,et al.  Characteristics and Short-Term Prognosis of Perioperative Myocardial Infarction in Patients Undergoing Noncardiac Surgery , 2011, Annals of Internal Medicine.

[125]  D. Angiolillo,et al.  Diabetes and Antiplatelet Therapy in Acute Coronary Syndrome , 2011, Circulation.

[126]  C. Held,et al.  Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO (Platelet Inhibition and Patient Outcomes) trial. , 2011, Journal of the American College of Cardiology.

[127]  H. Katus,et al.  Troponin elevation in coronary vs. non-coronary disease. , 2011, European heart journal.

[128]  L. Badano,et al.  Usefulness of contrast stress-echocardiography or exercise-electrocardiography to predict long-term acute coronary syndromes in patients presenting with chest pain without electrocardiographic abnormalities or 12-hour troponin elevation. , 2011, The American journal of cardiology.

[129]  J. McMurray,et al.  Eplerenone in patients with systolic heart failure and mild symptoms. , 2011, The New England journal of medicine.

[130]  F. Eberli,et al.  Drug-eluting versus bare-metal stents in large coronary arteries. , 2010, The New England journal of medicine.

[131]  A. Greinacher,et al.  Thrombocytopenia in the intensive care unit patient. , 2010, Hematology. American Society of Hematology. Education Program.

[132]  K. Harjai,et al.  Drug-Eluting Stents in Patients with Chronic Kidney Disease: A Prospective Registry Study , 2010, PloS one.

[133]  R. Collins,et al.  Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials , 2010, The Lancet.

[134]  H. Bruck,et al.  Effects of renal impairment on the pharmacokinetics, pharmacodynamics and safety of rivaroxaban, an oral, direct Factor Xa inhibitor. , 2010, British journal of clinical pharmacology.

[135]  James McCord,et al.  Testing of low-risk patients presenting to the emergency department with chest pain: a scientific statement from the American Heart Association. , 2010, Circulation.

[136]  G. Stone,et al.  Surgical versus percutaneous revascularization for multivessel disease in patients with acute coronary syndromes: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. , 2010, JACC. Cardiovascular interventions.

[137]  M. Keltai,et al.  Coronary Heart Disease Ticagrelor Versus Clopidogrel in Acute Coronary Syndromes in Relation to Renal Function Results From the Platelet Inhibition and Patient Outcomes (PLATO) Trial , 2010 .

[138]  S. Stevens,et al.  Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes (PLATO) trial , 2010, European heart journal.

[139]  C. Terkelsen,et al.  System delay and mortality among patients with STEMI treated with primary percutaneous coronary intervention. , 2010, JAMA.

[140]  L. Wallentin,et al.  Relation between renal function, presentation, use of therapies and in‐hospital complications in acute coronary syndrome: data from the SWEDEHEART register , 2010, Journal of internal medicine.

[141]  J. McCullough.  Overview of platelet transfusion. , 2010, Seminars in hematology.

[142]  R. de Caterina,et al.  Controversies in cardiovascular medicine Glycaemic control in acute coronary syndromes : prognostic value and therapeutic options , 2010 .

[143]  A. Prasad,et al.  Proposed Mayo Clinic criteria for the diagnosis of Tako-Tsubo cardiomyopathy and long-term prognosis , 2010, Herz.

[144]  John A Spertus,et al.  Association between use of bleeding avoidance strategies and risk of periprocedural bleeding among patients undergoing percutaneous coronary intervention. , 2010, JAMA.

[145]  S. Pocock,et al.  Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome a meta-analysis of individual patient data. , 2010, Journal of the American College of Cardiology.

[146]  K. Eagle,et al.  The Global Registry of Acute Coronary Events, 1999 to 2009–GRACE , 2010, Heart.

[147]  J. Hodges,et al.  CORONARY ARTERY DISEASE Original Studies Patients with Coronary Artery Disease Not Amenable to Traditional Revascularization: Prevalence and 3-Year Mortality , 2010 .

[148]  James E Tcheng,et al.  Impact of delay to angioplasty in patients with acute coronary syndromes undergoing invasive management: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial. , 2010, Journal of the American College of Cardiology.

[149]  B. Scirica,et al.  Acute coronary syndrome: emerging tools for diagnosis and risk assessment. , 2010, Journal of the American College of Cardiology.

[150]  L. A. Bonet,et al.  ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2010, European journal of heart failure.

[151]  E. Ohman,et al.  Timing of in-hospital coronary artery bypass graft surgery for non-ST-segment elevation myocardial infarction patients results from the National Cardiovascular Data Registry ACTION Registry-GWTG (Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With The Guidelines). , 2010, JACC. Cardiovascular interventions.

[152]  B. Hemmelgarn,et al.  Timing of nonemergent coronary artery bypass grafting and mortality after non-ST elevation acute coronary syndrome. , 2010, American heart journal.

[153]  S. Yusuf,et al.  Association of Diet, Exercise, and Smoking Modification With Risk of Early Cardiovascular Events After Acute Coronary Syndromes , 2010, Circulation.

[154]  G. Angelini,et al.  Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial. , 2010, Journal of the American College of Cardiology.

[155]  K. Alexander,et al.  Use of Evidence-Based Therapies in Short-Term Outcomes of ST-Segment Elevation Myocardial Infarction and Non–ST-Segment Elevation Myocardial Infarction in Patients With Chronic Kidney Disease: A Report From the National Cardiovascular Data Acute Coronary Treatment and Intervention Outcomes Network R , 2010, Circulation.

[156]  K. Schulman,et al.  Relationship Between Cardiac Rehabilitation and Long-Term Risks of Death and Myocardial Infarction Among Elderly Medicare Beneficiaries , 2010, Circulation.

[157]  Gregg W Stone,et al.  Platelet inhibition with cangrelor in patients undergoing PCI. , 2009, The New England journal of medicine.

[158]  Deepak L. Bhatt,et al.  Intravenous platelet blockade with cangrelor during PCI. , 2009, The New England journal of medicine.

[159]  Stefan Blankenberg,et al.  Sensitive troponin I assay in early diagnosis of acute myocardial infarction. , 2009, The New England journal of medicine.

[160]  Tobias Reichlin,et al.  Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. , 2009, The New England journal of medicine.

[161]  S. Yusuf,et al.  Early versus delayed invasive intervention in acute coronary syndromes. , 2009, The New England journal of medicine.

[162]  Sean M. O'Brien,et al.  Reoperation for Bleeding in Patients Undergoing Coronary Artery Bypass Surgery: Incidence, Risk Factors, Time Trends, and Outcomes , 2009, Circulation. Cardiovascular quality and outcomes.

[163]  Claes Held,et al.  Ticagrelor versus clopidogrel in patients with acute coronary syndromes. , 2009, The New England journal of medicine.

[164]  L. Wallentin,et al.  Influence of Renal Function on the Effects of Early Revascularization in Non–ST-Elevation Myocardial Infarction: Data From the Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART) , 2009, Circulation.

[165]  E. Vicaut,et al.  Immediate vs delayed intervention for acute coronary syndromes: a randomized clinical trial. , 2009, JAMA.

[166]  E. Hannan,et al.  Safety and Efficacy of Drug-Eluting and Bare Metal Stents: Comprehensive Meta-Analysis of Randomized Trials and Observational Studies , 2009, Circulation.

[167]  N. Morgenthaler,et al.  Incremental value of copeptin for rapid rule out of acute myocardial infarction. , 2009, Journal of the American College of Cardiology.

[168]  G. Montalescot,et al.  Can we override clopidogrel resistance? , 2009, Circulation.

[169]  D. Roberts,et al.  Immediate versus deferred coronary angioplasty in non-ST-segment elevation acute coronary syndromes , 2009 .

[170]  G. Mancia,et al.  When should antihypertensive drug treatment be initiated and to what levels should systolic blood pressure be lowered? A critical reappraisal , 2009, Journal of hypertension.

[171]  S. Pocock,et al.  Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials , 2009, The Lancet.

[172]  D. Angiolillo.  Antiplatelet Therapy in Diabetes: Efficacy and Limitations of Current Treatment Strategies and Future Directions , 2009, Diabetes Care.

[173]  S. Vesely,et al.  Oral Vitamin K Versus Placebo to Correct Excessive Anticoagulation in Patients Receiving Warfarin , 2009, Annals of Internal Medicine.

[174]  A. Kastrati,et al.  Patterns of Presentation and Outcomes of Patients with Acute Coronary Syndromes , 2009, Cardiology.

[175]  S. Bélisle,et al.  Efficacy and safety of activated recombinant factor VII in cardiac surgical patients , 2009, Current opinion in anaesthesiology.

[176]  G. Montalescot,et al.  Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study , 2009, The Lancet.

[177]  A. Iskandrian,et al.  Takotsubo cardiomyopathy: State-of-the-art review , 2009, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[178]  J. Gore,et al.  Thrombocytopenia in patients with an acute coronary syndrome (from the Global Registry of Acute Coronary Events [GRACE]). , 2009, The American journal of cardiology.

[179]  I. Palacios,et al.  Sex Differences in Medical Care and Early Death After Acute Myocardial Infarction , 2008, Circulation.

[180]  R. D. de Winter,et al.  A new ECG sign of proximal LAD occlusion. , 2008, The New England journal of medicine.

[181]  V. Vaccarino,et al.  Sex differences in mortality after acute myocardial infarction: changes from 1994 to 2006. , 2009, Archives of internal medicine.

[182]  D. Mark,et al.  Implantable Cardioverter Defibrillator Therapy in Patients with Prior Coronary Revascularization in the Sudden Cardiac Death in Heart Failure Trial (SCD‐HeFT) , 2008, Journal of cardiovascular electrophysiology.

[183]  A. Shah,et al.  Sodium bicarbonate vs sodium chloride for the prevention of contrast medium-induced nephropathy in patients undergoing coronary angiography: a randomized trial. , 2008, JAMA.

[184]  R. Cury,et al.  Cardiac Magnetic Resonance With T2-Weighted Imaging Improves Detection of Patients With Acute Coronary Syndrome in the Emergency Department , 2008, Circulation.

[185]  U. Sechtem,et al.  Coronary artery spasm as a frequent cause of acute coronary syndrome: The CASPAR (Coronary Artery Spasm in Patients With Acute Coronary Syndrome) Study. , 2008, Journal of the American College of Cardiology.

[186]  M. Sabatine,et al.  Early invasive vs conservative treatment strategies in women and men with unstable angina and non-ST-segment elevation myocardial infarction: a meta-analysis. , 2008, JAMA.

[187]  P. Kolh,et al.  Guideline on antiplatelet and anticoagulation management in cardiac surgery. , 2008, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[188]  Sunil V. Rao,et al.  Transfusion practice and outcomes in non-ST-segment elevation acute coronary syndromes. , 2008, American heart journal.

[189]  M. Fromm,et al.  Cytochrome P450 2C19 681G>A polymorphism and high on-clopidogrel platelet reactivity associated with adverse 1-year clinical outcome of elective percutaneous coronary intervention with drug-eluting or bare-metal stents. , 2008, Journal of the American College of Cardiology.

[190]  K. Eagle,et al.  Sex-related differences in the presentation, treatment and outcomes among patients with acute coronary syndromes: the Global Registry of Acute Coronary Events , 2008, Heart.

[191]  M. Keltai,et al.  Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial , 2008, The Lancet.

[192]  S. Yusuf,et al.  Telmisartan, ramipril, or both in patients at high risk for vascular events. , 2008, The New England journal of medicine.

[193]  J. Eikelboom,et al.  The effect of pre-operative aspirin on bleeding, transfusion, myocardial infarction, and mortality in coronary artery bypass surgery: a systematic review of randomized and observational studies. , 2008, European heart journal.

[194]  J D Hilton,et al.  Association of the arterial access site at angioplasty with transfusion and mortality: the M.O.R.T.A.L study (Mortality benefit Of Reduced Transfusion after percutaneous coronary intervention via the Arm or Leg) , 2008, Heart.

[195]  D. Yuh,et al.  Optimal timing of coronary artery bypass after acute myocardial infarction: a review of California discharge data. , 2008, The Journal of thoracic and cardiovascular surgery.

[196]  A. Kastrati,et al.  Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions: appropriateness of including bleeding as a component of a quadruple end point. , 2008, Journal of the American College of Cardiology.

[197]  G. Davı̀,et al.  Platelet activation and atherothrombosis. , 2007, The New England journal of medicine.

[198]  Á. Avezum,et al.  Management and 6-month outcomes in elderly and very elderly patients with high-risk non-ST-elevation acute coronary syndromes: The Global Registry of Acute Coronary Events. , 2007, European heart journal.

[199]  J. Ware,et al.  Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management: one-year results from the ACUITY trial. , 2007, JAMA.

[200]  T. Heer,et al.  Effect of an invasive strategy on in-hospital outcome in elderly patients with non-ST-elevation myocardial infarction. , 2007, European heart journal.

[201]  E. Antman,et al.  Prasugrel versus clopidogrel in patients with acute coronary syndromes. , 2007, The New England journal of medicine.

[202]  R. Virmani,et al.  Frequency and distribution of thin-cap fibroatheroma and ruptured plaques in human coronary arteries: a pathologic study. , 2007, Journal of the American College of Cardiology.

[203]  S. Yusuf,et al.  Influence of Renal Function on the Efficacy and Safety of Fondaparinux Relative to Enoxaparin in NonST-Segment Elevation Acute Coronary Syndromes , 2007, Annals of Internal Medicine.

[204]  Christopher P Cannon,et al.  Diabetes and mortality following acute coronary syndromes. , 2007, JAMA.

[205]  W. Gibler,et al.  Impact of acute beta-blocker therapy for patients with non-ST-segment elevation myocardial infarction. , 2007, The American journal of medicine.

[206]  Samin K. Sharma,et al.  Cardiac Angiography in Renally Impaired Patients (CARE) Study: A Randomized Double-Blind Trial of Contrast-Induced Nephropathy in Patients With Chronic Kidney Disease , 2007, Circulation.

[207]  A. Yan,et al.  Management patterns in relation to risk stratification among patients with non-ST elevation acute coronary syndromes. , 2007, Archives of internal medicine.

[208]  M. Naylor,et al.  Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology. , 2007, Circulation.

[209]  K. Alexander,et al.  Characteristics, management, and outcomes of 5,557 patients age > or =90 years with acute coronary syndromes: results from the CRUSADE Initiative. , 2007, Journal of the American College of Cardiology.

[210]  T. Warkentin,et al.  Focus on Research: Drug-Induced Immune-Mediated Thrombocytopenia — From Purpura to Thrombosis , 2007 .

[211]  William W O'Neill,et al.  A randomized controlled trial of multi-slice coronary computed tomography for evaluation of acute chest pain. , 2007, Journal of the American College of Cardiology.

[212]  Deepak L. Bhatt,et al.  In unstable angina or non-ST-segment acute coronary syndrome, should patients with multivessel coronary artery disease undergo multivessel or culprit-only stenting? , 2007, Journal of the American College of Cardiology.

[213]  J. Ware,et al.  Routine upstream initiation vs deferred selective use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: the ACUITY Timing trial. , 2007, JAMA.

[214]  G. Schuler,et al.  Incidence, time course, and predictors of early malignant ventricular arrhythmias after non-ST-segment elevation myocardial infarction in patients with early invasive treatment. , 2006, European heart journal.

[215]  P. Serruys,et al.  The long-term value of sirolimus- and paclitaxel-eluting stents over bare metal stents in patients with diabetes mellitus. , 2006, European heart journal.

[216]  Adelaide,et al.  Bivalirudin for patients with acute coronary syndromes. , 2006, The New England journal of medicine.

[217]  F. Burzotta,et al.  A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease. , 2006, European heart journal.

[218]  Deepak L. Bhatt,et al.  Benefit of early invasive therapy in acute coronary syndromes: a meta-analysis of contemporary randomized clinical trials. , 2006, Journal of the American College of Cardiology.

[219]  K. Alexander,et al.  Sex Differences in Major Bleeding With Glycoprotein IIb/IIIa Inhibitors: Results From the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the ACC/AHA Guidelines) Initiative , 2006, Circulation.

[220]  Young‐Bae Park,et al.  Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial. , 2006, Journal of the American College of Cardiology.

[221]  L. Rydén,et al.  Oral glucose tolerance test is needed for appropriate classification of glucose regulation in patients with coronary artery disease: a report from the Euro Heart Survey on Diabetes and the Heart , 2006, Heart.

[222]  N. Doll,et al.  Emergency Coronary Artery Bypass Graft Surgery for Acute Coronary Syndrome: Beating Heart Versus Conventional Cardioplegic Cardiac Arrest Strategies , 2006, Circulation.

[223]  H. White,et al.  Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction. , 2006, JAMA.

[224]  J. Critchley,et al.  Mortality reductions in patients receiving exercise-based cardiac rehabilitation: how much can be attributed to cardiovascular risk factor improvements? , 2006, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[225]  R. Virmani,et al.  Pathology of the Vulnerable Plaque , 2006 .

[226]  Salim Yusuf,et al.  Comparison of fondaparinux and enoxaparin in acute coronary syndromes. , 2006, The New England journal of medicine.

[227]  M. Simoons,et al.  Age, clinical presentation, and outcome of acute coronary syndromes in the Euroheart acute coronary syndrome survey. , 2006, European heart journal.

[228]  F. Van de Werf,et al.  Intervention in acute coronary syndromes: do patients undergo intervention on the basis of their risk characteristics? The Global Registry of Acute Coronary Events (GRACE) , 2005, Heart.

[229]  L. Wallentin,et al.  Diabetes mellitus: clinical presentation and outcome in men and women with acute coronary syndromes. Data from the Euro Heart Survey ACS , 2005, Diabetic medicine : a journal of the British Diabetic Association.

[230]  F. Van de Werf,et al.  Non-ST-segment elevation acute coronary syndrome in patients with renal dysfunction: benefit of low-molecular-weight heparin alone or with glycoprotein IIb/IIIa inhibitors on outcomes. The Global Registry of Acute Coronary Events. , 2005, European heart journal.

[231]  Lisa Hartling,et al.  Meta-Analysis: Secondary Prevention Programs for Patients with Coronary Artery Disease , 2005, Annals of Internal Medicine.

[232]  S. Kaul,et al.  Myocardial contrast echocardiography versus Thrombolysis In Myocardial Infarction score in patients presenting to the emergency department with chest pain and a nondiagnostic electrocardiogram. , 2005, Journal of the American College of Cardiology.

[233]  H. Boshuizen,et al.  Effect Size Estimates of Lifestyle and Dietary Changes on All-Cause Mortality in Coronary Artery Disease Patients: A Systematic Review , 2005, Circulation.

[234]  J. Spertus,et al.  Frequency of undiagnosed diabetes mellitus in patients with acute coronary syndrome. , 2005, The American journal of cardiology.

[235]  Darren K Mcguire,et al.  Association between hyper- and hypoglycaemia and 2 year all-cause mortality risk in diabetic patients with acute coronary events. , 2005, European heart journal.

[236]  B. Gersh,et al.  Methods of coronary revascularization--things may not be as they seem. , 2005, The New England journal of medicine.

[237]  C. Terkelsen,et al.  Mortality rates in patients with ST-elevation vs. non-ST-elevation acute myocardial infarction: observations from an unselected cohort. , 2005, European heart journal.

[238]  G. Stone,et al.  Outcomes with the paclitaxel-eluting stent in patients with acute coronary syndromes: analysis from the TAXUS-IV trial. , 2005, Journal of the American College of Cardiology.

[239]  L. Newby,et al.  Gender disparities in the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: large-scale observations from the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the American College of Cardiology/Ameri , 2005, Journal of the American College of Cardiology.

[240]  A. Cohen-Solal,et al.  Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). , 2005, European heart journal.

[241]  Douglas L Packer,et al.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. , 2005, The New England journal of medicine.

[242]  L. Rydén,et al.  Newly detected abnormal glucose tolerance: an important predictor of long-term outcome after myocardial infarction. , 2004, European heart journal.

[243]  M. Tonelli,et al.  The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease. , 2004, Journal of the American College of Cardiology.

[244]  Sunil V. Rao,et al.  Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. , 2004, JAMA.

[245]  P. Poole‐Wilson,et al.  Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial , 2004, The Lancet.

[246]  S. Nakamura,et al.  Electrocardiographic features in patients with acute myocardial infarction associated with left main coronary artery occlusion , 2004, Heart.

[247]  Christopher P Cannon,et al.  Intensive versus moderate lipid lowering with statins after acute coronary syndromes. , 2004, The New England journal of medicine.

[248]  E. Braunwald,et al.  The Effect of Routine, Early Invasive Management on Outcome for Elderly Patients with NonST-Segment Elevation Acute Coronary Syndromes , 2004, Annals of Internal Medicine.

[249]  David Brieger,et al.  Acute coronary syndromes without chest pain, an underdiagnosed and undertreated high-risk group: insights from the Global Registry of Acute Coronary Events. , 2004, Chest.

[250]  G. Biondi-Zoccai,et al.  Radial versus femoral approach for percutaneous coronary diagnostic and interventional procedures; Systematic overview and meta-analysis of randomized trials. , 2004, Journal of the American College of Cardiology.

[251]  R. Califf,et al.  Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial. , 2004, JAMA.

[252]  R. Bersin,et al.  Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. , 2004, JAMA.

[253]  S. Ebrahim,et al.  Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials. , 2004, The American journal of medicine.

[254]  E. Topol,et al.  Thrombocytopenia Caused by Abciximab or Tirofiban and Its Association With Clinical Outcome in Patients Undergoing Coronary Stenting , 2004, Circulation.

[255]  K. Eagle,et al.  Impact of Combination Evidence-Based Medical Therapy on Mortality in Patients With Acute Coronary Syndromes , 2004, Circulation.

[256]  Robert P. Giugliano,et al.  Differential Expression of Cardiac Biomarkers by Gender in Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction: A TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy–Thrombolysis In Myocardial Infarction 18) Substudy , 2004, Circulation.

[257]  A. Cohen-Solal,et al.  Determinants and Prognostic Impact of Heart Failure Complicating Acute Coronary Syndromes: Observations From the Global Registry of Acute Coronary Events (GRACE) , 2004, Circulation.

[258]  E. Topol,et al.  Percutaneous coronary intervention in diabetic patients with non-ST-segment elevation acute coronary syndromes. , 2004, European heart journal.

[259]  D. Altman,et al.  Indirect comparison meta-analysis of aspirin therapy after coronary surgery , 2003, BMJ : British Medical Journal.

[260]  Karl Swedberg,et al.  Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. , 2003, The New England journal of medicine.

[261]  Á. Avezum,et al.  Predictors of hospital mortality in the global registry of acute coronary events. , 2003, Archives of internal medicine.

[262]  Karl Swedberg,et al.  Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial , 2003, The Lancet.

[263]  K. Fox,et al.  Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study) , 2003, The Lancet.

[264]  A. Kastrati,et al.  Gender and restenosis after coronary artery stenting. , 2003, European heart journal.

[265]  J. Critchley,et al.  Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. , 2003, JAMA.

[266]  B. Pitt,et al.  Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction , 2003 .

[267]  P. Aspelin,et al.  Nephrotoxic effects in high-risk patients undergoing angiography. , 2003, The New England journal of medicine.

[268]  R. Califf,et al.  The Determinants of Activated Partial Thromboplastin Time, Relation of Activated Partial Thromboplastin Time to Clinical Outcomes, and Optimal Dosing Regimens for Heparin Treated Patients with Acute Coronary Syndromes: A Review of GUSTO-IIb , 2002, Journal of Thrombosis and Thrombolysis.

[269]  K. Fox,et al.  Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial , 2002, The Lancet.

[270]  E. Amsterdam,et al.  Immediate Exercise Testing to Evaluate Low‐Risk Patients Presenting to the Emergency Department with Chest Pain. , 2002, Journal of the American College of Cardiology.

[271]  A. Hamsten,et al.  Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study , 2002, The Lancet.

[272]  W. Boden,et al.  Revisiting the culprit lesion in non-Q-wave myocardial infarction. Results from the VANQWISH trial angiographic core laboratory. , 2002, Journal of the American College of Cardiology.

[273]  J. Oss,et al.  PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION , 2002 .

[274]  A. Kastrati,et al.  Sex-based analysis of outcome in patients with acute myocardial infarction treated predominantly with percutaneous coronary intervention. , 2002, JAMA.

[275]  Deepak L. Bhatt,et al.  Platelet Glycoprotein IIb/IIIa Inhibitors Reduce Mortality in Diabetic Patients With Non–ST-Segment-Elevation Acute Coronary Syndromes , 2001, Circulation.

[276]  S. Yusuf,et al.  Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. , 2001, The New England journal of medicine.

[277]  R. Califf,et al.  Prognostic value of ST segment depression in acute coronary syndromes: insights from PARAGON-A applied to GUSTO-IIb. PARAGON-A and GUSTO IIb Investigators. Platelet IIb/IIIa Antagonism for the Reduction of Acute Global Organization Network. , 2001, Journal of the American College of Cardiology.

[278]  E. Braunwald,et al.  Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. , 2001, The New England journal of medicine.

[279]  D. DeMets,et al.  Effect of carvedilol on survival in severe chronic heart failure. , 2001, The New England journal of medicine.

[280]  H. Dargie,et al.  Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial , 2001, The Lancet.

[281]  J. Kelton,et al.  Temporal aspects of heparin-induced thrombocytopenia. , 2001, The New England journal of medicine.

[282]  J. Parrillo,et al.  Electrocardiographic diagnosis of acute myocardial infarction: Current concepts for the clinician. , 2001, American heart journal.

[283]  W. O’Neill,et al.  Multiple complex coronary plaques in patients with acute myocardial infarction. , 2000, The New England journal of medicine.

[284]  J. W. Box,et al.  Platelet glycoprotein IIb/IIIa blockade and outcome of cardiogenic shock complicating acute coronary syndromes without persistent ST-segment elevation. , 2000, Journal of the American College of Cardiology.

[285]  E. Antman,et al.  The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making. , 2000, JAMA.

[286]  F. Menapace,et al.  Thrombocytopenia complicating treatment with intravenous glycoprotein IIb/IIIa receptor inhibitors: a pooled analysis. , 2000, American heart journal.

[287]  L. Wallentin,et al.  Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial , 2000, The Lancet.

[288]  S. Yusuf,et al.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. , 2000 .

[289]  R. Califf,et al.  Cardiogenic shock in patients with acute ischemic syndromes with and without ST-segment elevation. , 1999, Circulation.

[290]  O. Benavente,et al.  Antithrombotic Therapy To Prevent Stroke in Patients with Atrial Fibrillation , 1999, Annals of Internal Medicine.

[291]  B. Pitt,et al.  The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. , 1999, The New England journal of medicine.

[292]  H. White,et al.  Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. , 1999, The New England journal of medicine.

[293]  R. Califf,et al.  Clinical significance of thrombocytopenia during a non-ST-elevation acute coronary syndrome. The platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial experience. , 1999, Circulation.

[294]  CIBIS-II Investigators and Committees.  The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial , 1999, The Lancet.

[295]  S. Gottlieb,et al.  Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. , 1998, The New England journal of medicine.

[296]  Joël Ménard,et al.  Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial , 1998, The Lancet.

[297]  A. Takeshita,et al.  Angina pectoris caused by coronary microvascular spasm , 1998, The Lancet.

[298]  A. Ciampi,et al.  Additive beneficial effects of beta-blockers to angiotensin-converting enzyme inhibitors in the Survival and Ventricular Enlargement (SAVE) Study. SAVE Investigators. , 1997, Journal of the American College of Cardiology.

[299]  E. J. Brown,et al.  Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. , 1992, The New England journal of medicine.

[300]  V. Gebski,et al.  Immediate Postoperative Aspirin Improves Vein Graft Patency Early and Late After Coronary Artery Bypass Graft Surgery: A Placebo‐Controlled, Randomized Study , 1991, Circulation.

[301]  H L Greene,et al.  Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. , 1991, The New England journal of medicine.

[302]  J. Wittes,et al.  Overview of results of randomized clinical trials in heart disease. I. Treatments following myocardial infarction. , 1988, JAMA.

[303]  A. Maseri,et al.  Comparison of verapamil and propranolol therapy for angina pectoris at rest: a randomized, multiple-crossover, controlled trial in the coronary care unit. , 1986, The American journal of cardiology.

[304]  Louis E. Teichholz,et al.  Angiographie morphology and the pathogenesis of unstable angina pectoris , 1985 .

[305]  G. Minno,et al.  Monitoring the entry of new platelets into the circulation after ingestion of aspirin. , 1983, Blood.

[306]  L. Campeau.  Letter: Grading of angina pectoris. , 1976, Circulation.

[307]  Seung‐Jung Park,et al.  Pancoronary plaque vulnerability in patients with acute coronary syndrome and ruptured culprit plaque: a 3-vessel optical coherence tomography study. , 2014, American heart journal.

[308]  J. Marchesini,et al.  Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre-specified analysis from the PRODIGY study (PROlonging Dual Antiplatelet Treatment After Grading stent-induced Intimal hyperplas , 2014, JACC. Cardiovascular interventions.

[309]  A. Kastrati,et al.  Weight of the bleeding impact on early and late mortality after percutaneous coronary intervention , 2014, Journal of Thrombosis and Thrombolysis.

[310]  D. Fintel,et al.  Eptifibatide-induced thrombocytopenia: with thrombosis and disseminated intravascular coagulation immediately after left main coronary artery percutaneous coronary angioplasty. , 2012, Texas Heart Institute journal.

[311]  G. Gensini,et al.  [Epidemiology of Tako-tsubo cardiomyopathy: the Tuscany Registry for Tako-tsubo Cardiomyopathy ]. , 2012, Giornale italiano di cardiologia.

[312]  Arlene S Bierman,et al.  Bridging the gender gap: Insights from a contemporary analysis of sex-related differences in the treatment and outcomes of patients with acute coronary syndromes. , 2012, American heart journal.

[313]  J. Ioannidis,et al.  Optimal timing of coronary angiography and potential intervention in non-ST-elevation acute coronary syndromes , 2012 .

[314]  S. Yusuf,et al.  Relationship between baseline haemoglobin and major bleeding complications in acute coronary syndromes. , 2010, European heart journal.

[315]  E. Topol,et al.  Tirofiban as adjunctive therapy for acute coronary syndromes and percutaneous coronary intervention: a meta-analysis of randomized trials. , 2010, European heart journal.

[316]  M. Mack,et al.  Clinical outcomes of nonelective coronary revascularization with and without cardiopulmonary bypass. , 2006, The Journal of thoracic and cardiovascular surgery.

[317]  W. Geerts,et al.  Anticoagulant Use in Patients with Chronic Renal Impairment , 2005, American journal of cardiovascular drugs : drugs, devices, and other interventions.